Tag: ABL
ABL Diagnostics adjuvants PALEX to offer NGS genotyping applications & Sanger to microbiology laboratories in Spain. – 03/18/2024 at 08:00
Woippy (France) – ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories is announcing today the execution of a…
Sale of blocks of ordinary shares of ABL Diagnostics (ABLD, Euronext, compartment B) – 03/04/2024 at 08:00
ABL Diagnostics (FR001400AHX6) (“ABLD” or the “Company”) announced today that, since August 2023, three dispositions, for a total of 59,651 of its ordinary shares, have been reported to ONDE, the…
ABL Diagnostics announces the release of its DeepChek®-HPV Assay, to be used for Human Papillomavirus screening, genotyping, and discrimination through sequencing. – 01/18/2024 at 10:00
Woippy (France) – ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories is pleased to announce today the release…
ABL DIAGNOSTICS OBTAINS QUALITY CERTIFICATION ISO 13485:2016 – 11/16/2022 at 18:00
ABL Diagnostics (Euronext Paris, FR001400AHX6, ABLD), specializing in the development of diagnostic tests for infectious diseases, based on genotyping by sequencing, is pleased to announce that it has obtained ISO…
ABL Diagnostics: signature of the merger agreement
(Boursier.com) — The Board of Directors of the company ABL Diagnostics of June 13, approved the merger-absorption plan under which the company is expected to absorb Advanced Biological Laboratories Fedialis…